Tyra Bioscience Announces New Purchase Agreement
Company Announcements

Tyra Bioscience Announces New Purchase Agreement

Tyra Bioscience (TYRA) has released an update to notify the public and investors about a regulation fd disclosure.

On February 2, 2024, the Company announced a new Purchase Agreement via a press release, signaling an important development for investors to consider. This announcement, while provided for informational purposes, does not constitute a formal legal filing, but it may influence the company’s stock as the market responds to this news.

For further insights into TYRA stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlyTyra Biosciences price target lowered to $29 from $31 at BofA
TheFlyTyra Biosciences price target lowered to $30 from $32 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskTyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App